You are here : Home > Diabeloop shifts into high gear in France and around the globe

News

Diabeloop shifts into high gear in France and around the globe


Diabeloop obtained French national health insurance approval for its DBLG1 closed-loop automated insulin therapy device (DBLG1) in September. 

Published on 10 March 2022

​Now the Grenoble start-up and long-time CEA-Leti partner is training hospital staff so that they can offer the DBLG1 to their diabetic patients. Hospitals in the Île-de-France and Auvergne-Rhône-Alpes regions recently set their first patients up with the device, which will be rolled out gradually throughout France in 2022. And Diabeloop is also expanding internationally.

The company signed a partnership agreement with leading Japanese medical equipment manufacturer Terumo in mid-November. The partners will integrate Terumo's patch pump into Diabeloop's system so that the Japanese company can sell it in Europe.

Source: Minanews

Top page